Abiraterone Acetate Cost in Philippines, Malaysia, Thailand, UAE, USA vs India
September 21, 2026
Abiraterone Acetate is an important prescription medicine used in specific forms of advanced prostate cancer. For patients, families, hospitals, distributors and other medicine buyers, the question is often not simply whether Abiraterone Acetate is available, but why the overall cost and access can differ between countries.
The Philippines, Malaysia, Thailand, the United Arab Emirates, the United States and India have different pharmaceutical markets, regulatory systems, distribution channels, insurance structures and levels of generic availability. These differences can affect the final cost of treatment even when the active ingredient is the same.
This guide explains the main factors behind those differences and looks specifically at Abiraterone Acetate availability and cost considerations in the Philippines compared with India and other international markets.
Key Points
- Abiraterone Acetate is available in multiple pharmaceutical markets, including the Philippines, Malaysia, Thailand and the United States. Official regulatory records also show registered products in these markets.
- The Philippines has registered Abiraterone Acetate products, including 250 mg and 500 mg formulations, and the Philippine health technology assessment system has evaluated Abiraterone for metastatic castration-resistant prostate cancer.
- Malaysia and Thailand have both branded and generic Abiraterone Acetate products recorded in their regulatory databases, showing that availability is not limited to a single brand or supplier.
- India is an important source market for generic pharmaceutical products. For example, Philippine and Malaysian regulatory records identify Indian manufacturers for registered Abiraterone products.
- The actual amount paid for treatment can differ substantially from a published list figure because healthcare systems, insurance, procurement and distribution arrangements are different from one country to another.
- When comparing international options, medicine authenticity, regulatory status, manufacturer information and local import requirements matter as much as affordability.
Â
What Is Abiraterone Acetate?
Abiraterone Acetate is an oral prescription medicine that inhibits CYP17, an enzyme involved in androgen production. Current U.S. prescribing information lists Abiraterone Acetate in combination with prednisone for certain patients with metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer.
Regulatory information also demonstrates that Abiraterone Acetate is supplied in different strengths and formulations. The Philippine FDA database, for example, lists registered 250 mg and 500 mg products.
The medicine is prescription-only and should be used according to the treatment plan established by the patient’s qualified healthcare professional.
Why Do People Compare Abiraterone Acetate Cost Between Countries?
Long-term cancer treatment can involve several different expenses rather than a single medicine-related charge.
When buyers compare markets, they may be trying to understand:
- Whether a generic formulation is available
- Which manufacturers supply the market
- Whether the medicine is locally registered
- Whether treatment is mainly supplied through hospitals, pharmacies or specialty distributors
- Whether insurance or public reimbursement can contribute to treatment
- Whether the product is imported or manufactured domestically
- What distribution and procurement channels are involved
- Whether the required formulation and pack size are available
This is why comparing a single number from two countries can be misleading.
A product supplied through a hospital procurement system, for example, may not have the same final patient cost as the same active ingredient supplied through a private pharmacy or another distribution channel.
Abiraterone Acetate Cost in the Philippines
The Philippines is particularly relevant for this topic because Abiraterone Acetate is already represented in the country’s pharmaceutical and health technology records.
The Philippine FDA has records for Abiraterone Acetate products, including a 250 mg tablet product and other registered formulations. One official product record identifies an Abiraterone Acetate 250 mg tablet as a prescription medicine manufactured in India.
The Philippine Department of Science and Technology Health Technology Assessment Division has also published an assessment of Abiraterone Acetate 250 mg in combination with prednisone for metastatic castration-resistant prostate cancer, with the HTA Council recommending government financing through inclusion in the Philippine National Formulary in its 2022 recommendation.
There is also recent regulatory activity around Abiraterone in the Philippines. In July 2026, the HTA Council published a preliminary recommendation concerning 500 mg Abiraterone Acetate for first- or second-line treatment of metastatic castration-resistant prostate cancer.
Abiraterone Acetate Price In Malaysia
Malaysia also has documented regulatory records for Abiraterone Acetate.
The Malaysian National Pharmaceutical Regulatory Agency’s QUEST3+ database lists products such as Artesto 250 mg, with Abiraterone Acetate as the active ingredient. The record identifies Natco Pharma Limited in India as the manufacturer and a Malaysian company as the local holder/importer.
The Malaysian database also contains registered Abiraterone products from other manufacturers, including Abiratred 250 mg and branded Zytiga formulations.
Malaysia’s Ministry of Health also maintains the Malaysia Medicines Price Guide (MyPriMe). The ministry specifically notes that the guide is intended to help consumers make informed choices and that actual retail amounts can differ from the listed figures.
That distinction is important when researching Abiraterone cost in Malaysia. A reference figure is not necessarily the same as the final amount paid by every buyer.
Abiraterone Acetate Price in Thailand
Thailand’s official Food and Drug Administration drug database currently contains multiple entries for Abiraterone Acetate.
The database includes 250 mg and 500 mg products from different manufacturers, including generic products and the originator brand.
Thailand therefore provides another useful example of why international comparison should look beyond a single brand.
When researching Abiraterone Thailand or Abiraterone cost in Thailand, it is important to consider:
- Registered products
- Formulation and strength
- Manufacturer
- Distribution channel
- Hospital versus private-sector procurement
- Applicable local requirements
The availability of several registered products can create differences between suppliers and treatment settings.
Symptoms of Prostate Cancer
One of the biggest challenges is that early-stage prostate cancer often causes no noticeable symptoms. Many men are diagnosed after a routine PSA blood test or physical examination.
As the disease progresses, symptoms may begin to appear.
Common Symptoms
- Frequent urination, especially at night
- Difficulty starting urination
- Weak urine stream
- Interrupted urine flow
- Difficulty emptying the bladder
- Pain or burning during urination
- Blood in the urine
- Blood in semen
- Pain during ejaculation
These symptoms can also occur with non-cancerous conditions such as benign prostatic hyperplasia (BPH) or prostatitis, making proper medical evaluation essential.
Symptoms of Advanced Prostate Cancer
If prostate cancer spreads beyond the prostate gland, additional symptoms may develop, including:
- Persistent bone pain, particularly in the hips, pelvis, ribs, or spine
- Unexplained weight loss
- Ongoing fatigue
- Weakness in the legs
- Swelling of the legs or feet
- Difficulty walking
- Loss of appetite
Bone pain is one of the most common symptoms of metastatic prostate cancer because the disease frequently spreads to the bones.
How Is Prostate Cancer Diagnosed?
If screening tests or symptoms suggest prostate cancer, your healthcare provider may recommend additional tests to confirm the diagnosis and determine how far the cancer has spread. Accurate diagnosis is essential because treatment decisions depend on the cancer’s stage, grade, and your overall health.
1. PSA Blood Test
A PSA (Prostate-Specific Antigen) blood test is often the first step in evaluating prostate health. While an elevated PSA level can indicate prostate cancer, it may also be caused by benign prostatic hyperplasia (BPH), prostatitis, or other non-cancerous conditions. Your doctor will interpret PSA results alongside your age, medical history, and other clinical findings.
2. Multiparametric MRI (mpMRI)
If PSA levels or a Digital Rectal Examination (DRE) raise concerns, an mpMRI may be recommended. This advanced imaging test helps identify suspicious areas within the prostate and guides targeted biopsies, improving diagnostic accuracy while reducing unnecessary procedures.
3. Prostate Biopsy
A prostate biopsy is the only way to confirm prostate cancer. During this procedure, small tissue samples are collected from the prostate and examined under a microscope by a pathologist to determine whether cancer cells are present.
4. Gleason Score and Grade Group
If cancer is detected, the biopsy report includes a Gleason Score and Grade Group, which indicate how aggressive the cancer appears.
| Grade Group | Gleason Score | Risk Level |
|---|---|---|
| Grade Group 1 | 6 (3+3) | Low Risk |
| Grade Group 2 | 7 (3+4) | Favorable Intermediate |
| Grade Group 3 | 7 (4+3) | Unfavorable Intermediate |
| Grade Group 4 | 8 | High Risk |
| Grade Group 5 | 9–10 | Very High Risk |
Higher scores generally indicate faster-growing cancers that may require more intensive treatment.
Stages of Prostate Cancer
Doctors commonly use the TNM staging system to describe the extent of prostate cancer.
Stage I
- Small tumor confined to the prostate
- Usually grows slowly
- Excellent long-term outlook
Stage II
- Cancer remains within the prostate but may be larger or more aggressive
- Often curable with appropriate treatment
Stage III
- Cancer has spread beyond the prostate capsule to nearby tissues
- Requires more comprehensive treatment
Stage IV
- Cancer has spread to distant organs, bones, or lymph nodes
- Treatment focuses on controlling disease progression, relieving symptoms, and improving quality of life
Treatment Options for Prostate Cancer in the Philippines
Treatment depends on several factors, including:
- Cancer stage
- PSA level
- Grade Group
- Patient’s age
- Overall health
- Symptoms
- Personal preferences
Your healthcare team may include a urologist, medical oncologist, radiation oncologist, radiologist, and oncology nurses.
1- Active Surveillance
Not every prostate cancer requires immediate treatment.
For men with low-risk, slow-growing prostate cancer, doctors may recommend active surveillance.
This involves:
- Regular PSA testing
- Repeat MRI scans when appropriate
- Follow-up biopsies if indicated
- Routine medical evaluations
The goal is to monitor the cancer closely while avoiding unnecessary side effects from treatment unless the disease shows signs of progression.
2- Surgery (Radical Prostatectomy)
Radical prostatectomy removes the entire prostate gland and, in some cases, nearby lymph nodes.
It is commonly recommended for localized prostate cancer that has not spread outside the prostate.
Potential side effects include:
- Urinary incontinence
- Erectile dysfunction
- Temporary recovery challenges
Many patients experience significant improvement with rehabilitation and follow-up care.
3- Radiation Therapy
Radiation therapy uses high-energy beams to destroy cancer cells.
Common approaches include:
- External Beam Radiation Therapy (EBRT)
- Brachytherapy (internal radiation)
Radiation may be used:
- As the primary treatment
- After surgery
- Together with hormone therapy
- To relieve pain caused by bone metastases
4- Hormone Therapy (Androgen Deprivation Therapy)
Prostate cancer cells often rely on male hormones called androgens, particularly testosterone, to grow.
Hormone therapy lowers androgen levels or blocks their effects, slowing cancer growth.
Treatment may include:
- LHRH agonists
- LHRH antagonists
- Surgical removal of the testicles (orchiectomy)
- Androgen receptor pathway inhibitors
Hormone therapy is commonly used for:
- Advanced prostate cancer
- Recurrent disease
- Metastatic prostate cancer
- High-risk localized cancer combined with radiation therapy
Abiraterone for Advanced Prostate Cancer
What Is Abiraterone?
Abiraterone acetate is an oral medicine used to treat certain forms of advanced prostate cancer. It works by blocking an enzyme called CYP17, which plays a key role in the body’s production of androgens. By reducing androgen levels, Abiraterone helps slow the growth of prostate cancer cells.
Abiraterone is typically prescribed together with low-dose corticosteroids, such as prednisone, to help reduce the risk of certain side effects. It should only be taken exactly as directed by an oncologist.
Who May Benefit from Abiraterone?
Depending on a physician’s assessment and current treatment guidelines, Abiraterone may be considered for eligible patients with:
- Metastatic hormone-sensitive prostate cancer (mHSPC)
- Metastatic castration-resistant prostate cancer (mCRPC)
- Certain high-risk advanced prostate cancers
Treatment decisions are individualized based on the patient’s overall condition, prior therapies, and disease characteristics.
Possible Side Effects
Like all cancer medicines, Abiraterone can cause side effects, including:
- High blood pressure
- Low potassium levels
- Fluid retention or swelling
- Liver function changes
- Fatigue
- Joint discomfort
Regular blood tests and follow-up appointments are important throughout treatment.
Enzalutamide for Advanced Prostate Cancer
What Is Enzalutamide?
Enzalutamide is another oral medicine used in the treatment of advanced prostate cancer. Unlike Abiraterone, it directly blocks androgen receptors on prostate cancer cells, preventing testosterone from stimulating cancer growth.
When Is Enzalutamide Used?
Enzalutamide may be prescribed for selected patients with:
- Non-metastatic castration-resistant prostate cancer (nmCRPC)
- Metastatic castration-sensitive prostate cancer (mCSPC)
- Metastatic castration-resistant prostate cancer (mCRPC)
Your oncologist will determine whether Enzalutamide is an appropriate option based on your medical history and treatment goals.
Common Side Effects
Some patients may experience:
- Fatigue
- High blood pressure
- Hot flashes
- Dizziness
- Increased risk of falls
- Muscle weakness
Patients should report any new or worsening symptoms to their healthcare provider promptly.
Abiraterone vs. Enzalutamide
| Feature | Abiraterone | Enzalutamide |
|---|---|---|
| Administration | Oral tablet | Oral capsule/tablet |
| Main Action | Reduces androgen production | Blocks androgen receptor signaling |
| Often Given With | Prednisone or equivalent corticosteroid | Usually does not require routine corticosteroids |
| Common Use | Advanced prostate cancer | Advanced prostate cancer |
| Prescribed By | Medical oncologist or urologist | Medical oncologist or urologist |
Other Treatments That May Be Recommended
Depending on the stage and progression of prostate cancer, treatment plans may also include:
- Chemotherapy (such as docetaxel or cabazitaxel)
- Bone-strengthening medicines for bone metastases
- PARP inhibitors for selected patients with specific genetic mutations
- Radiopharmaceutical therapy for certain advanced cases
- Clinical trials when appropriate
Your oncology team will tailor treatment to your specific diagnosis and health needs.
Living with Prostate Cancer
Many men continue to lead active and fulfilling lives during and after treatment. Maintaining open communication with your healthcare team and adopting healthy lifestyle habits can support both physical and emotional well-being.
Helpful strategies include:
- Attending all scheduled follow-up appointments
- Taking medicines exactly as prescribed
- Eating a balanced diet rich in fruits, vegetables, and whole grains
- Staying physically active as advised by your healthcare provider
- Avoiding tobacco products
- Limiting alcohol consumption
- Seeking support from family, friends, or cancer support groups
Can Prostate Cancer Be Prevented?
There is no guaranteed way to prevent prostate cancer. However, you may reduce your overall health risks by:
- Maintaining a healthy weight
- Exercising regularly
- Eating a nutritious diet
- Avoiding smoking
- Managing chronic conditions such as diabetes and hypertension
- Discussing screening with your doctor if you have risk factors or a family history
Conclusion
Prostate cancer remains a significant health concern for Filipino men, but advances in screening, diagnosis, and treatment continue to improve outcomes. Recognizing symptoms early, discussing PSA screening with your healthcare provider when appropriate, and receiving timely specialist evaluation can make a substantial difference in treatment success.
For men with advanced prostate cancer, therapies such as Abiraterone and Enzalutamide have expanded treatment options and may help slow disease progression in eligible patients. Because every case is unique, treatment decisions should always be made in consultation with a qualified oncologist or urologist.
If you have been prescribed specialty medicines for prostate cancer, trusted providers such as LetsMeds can help patients access quality generic and branded oncology medicines. Always use these medications under the supervision of your treating physician and follow the prescribed treatment plan.
Frequently Asked Questions
Early prostate cancer often causes no symptoms. When symptoms do occur, they may include frequent urination, difficulty urinating, weak urine flow, blood in the urine or semen, and pelvic discomfort.
Prostate cancer is one of the most commonly diagnosed cancers among Filipino men, particularly those aged 50 years and older. Early detection and appropriate treatment have improved outcomes for many patients.
Yes. Many localized prostate cancers can be treated successfully, especially when diagnosed early. Even advanced prostate cancer can often be managed effectively with modern therapies that help control the disease and improve quality of life.
The PSA test is a blood test that measures prostate-specific antigen levels. It helps identify men who may need further evaluation but does not diagnose prostate cancer by itself.
Treatment may include hormone therapy, chemotherapy, and newer androgen receptor pathway inhibitors such as Abiraterone and Enzalutamide, depending on the patient’s diagnosis and treatment plan.
No. Both are targeted hormonal therapies that interfere with androgen signaling rather than directly destroying rapidly dividing cells like traditional chemotherapy.
References
- World Health Organization (WHO). Cancer Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/cancer
- International Agency for Research on Cancer (IARC) – Global Cancer Observatory (GCO). Philippines Cancer Statistics. https://gco.iarc.who.int/
- National Cancer Institute (NCI). Prostate Cancer Treatment (PDQ®). https://www.cancer.gov/types/prostate
- National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. https://www.nccn.org/guidelines
- American Cancer Society (ACS). Prostate Cancer. https://www.cancer.org/cancer/types/prostate-cancer.html
- European Association of Urology (EAU). EAU Guidelines on Prostate Cancer. https://uroweb.org/guidelines/prostate-cancer
- Department of Health (DOH), Philippines. National Integrated Cancer Control Act (NICCA) and Cancer Programs. https://doh.gov.ph/
- PhilHealth. Cancer Benefit Packages and Health Coverage. https://www.philhealth.gov.ph/
- U.S. Food and Drug Administration (FDA). Prescribing Information for Abiraterone Acetate and Enzalutamide. https://www.accessdata.fda.gov/